Alliance Global Partners Maintains Buy on Verastem, Lowers Price Target to $20

Benzinga · 05/29 16:55
Alliance Global Partners analyst Jeff Grampp maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $34 to $20.